FDA Hits Texas Drug Facility for Oversight of Pilot/Exhibit Batches

Drug Industry Daily
A A
The FDA cited Sovereign Pharmaceuticals for quality and other failures observed during a Dec. 11-19 inspection of its facility in Fort Worth, Texas—including its failure to ensure the quality of pilot or exhibit batches.

To View This Article:

Login

Subscribe To Drug Industry Daily